跳至主要内容
临床试验/IRCT20170916036204N6
IRCT20170916036204N6招募中3 期

Effect of kefir drink on hepatic enzymes, lipid profiles, glycemic indices,inflammation, oxidative stress, anthropometric factors and blood pressure in patients with non-alcoholic fatty liver disease.

Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • grade 1,2 & 3 fatty liver, new fatty liver diagnosed patients, and fatty liver confirmed by physician.
  • Alt>30 in males and ALt>19 in females.
  • age: 18-65
  • controlled Diabetes and lipid profile.

排除标准

  • presence of another type of liver disease, cirrhosis, hepatitis B and C, cardiovascular and kidney disease, autoimmune, hypothyroidism, wilson, cystic fibrosis, Deficiency of alpha-1-antitrypsin 1, inflammatory bowel disease and hemochromatosis.
  • using alcohol
  • taking nutritional and probiotic supplements within the previous 6 weeks.
  • having weight loss more than 3 Kg within 3 month ago
  • participating in other trials in the last 6 month
  • being pregnant or breast feeding
  • do not want to participate in this trial.

研究者

相似试验